OrganiGram Holdings Inc. (OGI)
USD 1.47
(-8.7%)
USD 1.47
(-8.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -229.47 Million CAD | -1506.65% |
| 2022 | -14.28 Million CAD | 89.22% |
| 2021 | -132.54 Million CAD | 2.65% |
| 2020 | -136.15 Million CAD | -1332.63% |
| 2019 | -9.5 Million CAD | -146.33% |
| 2018 | 20.51 Million CAD | 288.37% |
| 2017 | -10.88 Million CAD | -1386.19% |
| 2016 | 846.66 Thousand CAD | 166.31% |
| 2015 | -1.27 Million CAD | -433.56% |
| 2014 | -239.3 Thousand CAD | 36.23% |
| 2013 | -375.24 Thousand CAD | -167.72% |
| 2012 | -140.16 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -15.75 Million CAD | 52.26% |
| 2024 Q2 | -27.07 Million CAD | -71.9% |
| 2024 Q3 | 2.81 Million CAD | 110.41% |
| 2023 Q3 | -213.45 Million CAD | -2750.57% |
| 2023 FY | -229.47 Million CAD | -1506.66% |
| 2023 Q1 | 5.32 Million CAD | 186.74% |
| 2023 Q2 | -7.48 Million CAD | -240.51% |
| 2023 Q4 | -32.99 Million CAD | 84.54% |
| 2022 Q2 | -4.04 Million CAD | -210.11% |
| 2022 Q3 | -2.78 Million CAD | 31.13% |
| 2022 Q4 | -6.14 Million CAD | -120.45% |
| 2022 FY | -14.28 Million CAD | 89.22% |
| 2022 Q1 | -1.3 Million CAD | 94.98% |
| 2021 Q4 | -25.97 Million CAD | -547.98% |
| 2021 Q1 | -34.33 Million CAD | 11.02% |
| 2021 Q2 | -66.38 Million CAD | -93.35% |
| 2021 FY | -132.54 Million CAD | 2.65% |
| 2021 Q3 | -4 Million CAD | 93.96% |
| 2020 FY | -136.15 Million CAD | -1332.63% |
| 2020 Q1 | -863 Thousand CAD | 96.16% |
| 2020 Q2 | -6.83 Million CAD | -691.77% |
| 2020 Q3 | -89.87 Million CAD | -1215.25% |
| 2020 Q4 | -38.59 Million CAD | 57.06% |
| 2019 FY | -9.5 Million CAD | -146.33% |
| 2019 Q2 | -6.38 Million CAD | -121.66% |
| 2019 Q4 | -22.45 Million CAD | -120.57% |
| 2019 Q3 | -10.18 Million CAD | -59.41% |
| 2019 Q1 | 29.47 Million CAD | 63.62% |
| 2018 Q3 | 2.82 Million CAD | 162.08% |
| 2018 Q4 | 18.01 Million CAD | 538.9% |
| 2018 FY | 20.51 Million CAD | 288.37% |
| 2018 Q2 | 1.07 Million CAD | 176.76% |
| 2018 Q1 | -1.4 Million CAD | 31.06% |
| 2017 FY | -10.88 Million CAD | -1386.19% |
| 2017 Q4 | -2.03 Million CAD | 13.31% |
| 2017 Q1 | -755.54 Thousand CAD | -220.91% |
| 2017 Q2 | -5.75 Million CAD | -661.73% |
| 2017 Q3 | -2.34 Million CAD | 59.24% |
| 2016 Q4 | 624.88 Thousand CAD | 69.94% |
| 2016 FY | 846.66 Thousand CAD | 166.31% |
| 2016 Q3 | 367.72 Thousand CAD | 565.35% |
| 2016 Q2 | 55.26 Thousand CAD | 127.47% |
| 2016 Q1 | -201.21 Thousand CAD | -453.46% |
| 2015 Q2 | -634.93 Thousand CAD | 22.43% |
| 2015 Q1 | -818.53 Thousand CAD | -338.0% |
| 2015 FY | -1.27 Million CAD | -433.56% |
| 2015 Q4 | 56.92 Thousand CAD | -52.44% |
| 2015 Q3 | 119.69 Thousand CAD | 118.85% |
| 2014 Q3 | -24.18 Thousand CAD | -54.13% |
| 2014 Q2 | -15.69 Thousand CAD | 91.6% |
| 2014 Q1 | -186.75 Thousand CAD | -1373.63% |
| 2014 Q4 | -186.88 Thousand CAD | -672.61% |
| 2014 FY | -239.3 Thousand CAD | 36.23% |
| 2013 FY | -375.24 Thousand CAD | -167.72% |
| 2013 Q3 | -2962.00 CAD | 94.95% |
| 2013 Q1 | -252.8 Thousand CAD | -315.97% |
| 2013 Q4 | -12.67 Thousand CAD | -327.85% |
| 2013 Q2 | -58.7 Thousand CAD | 76.78% |
| 2012 Q2 | -81.03 Thousand CAD | -1168.18% |
| 2012 Q3 | -43.44 Thousand CAD | 46.39% |
| 2012 Q4 | -60.77 Thousand CAD | -39.9% |
| 2012 FY | -140.16 Thousand CAD | 0.0% |
| 2012 Q1 | -6390.00 CAD | 31.26% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | -9296.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Theratechnologies Inc. | -23.95 Million USD | -857.874% |
| Harrow Health, Inc. | -24.41 Million USD | -840.059% |
| Dynavax Technologies Corporation | -6.38 Million USD | -3491.765% |
| Biofrontera Inc. | -20.13 Million USD | -1039.923% |
| Cronos Group Inc. | -73.96 Million USD | -210.26% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -4646.181% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 77.103% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -443.799% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 1059.516% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -3554.502% |
| Radius Health, Inc. | -25.79 Million USD | -789.759% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -3623.44% |
| DURECT Corporation | -27.62 Million USD | -730.719% |
| ProPhase Labs, Inc. | -16.78 Million USD | -1267.405% |
| Safety Shot Inc | -15.08 Million USD | -1421.43% |
| Phibro Animal Health Corporation | 2.41 Million USD | 9598.256% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -7306.019% |
| Alvotech | -551.73 Million USD | 58.408% |
| Assertio Holdings, Inc. | -331.94 Million USD | 30.868% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 17537.528% |
| Rockwell Medical, Inc. | -8.43 Million USD | -2619.254% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -4992.668% |
| Procaps Group S.A. | 42.54 Million USD | 639.44% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | -64.295% |
| SCYNEXIS, Inc. | 67.04 Million USD | 442.295% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -1348.358% |
| Viatris Inc. | 54.7 Million USD | 519.521% |
| OptiNose, Inc. | -35.48 Million USD | -546.726% |
| SIGA Technologies, Inc. | 68.06 Million USD | 437.126% |
| Tilray Brands, Inc. | -244.98 Million USD | 6.328% |
| PetIQ, Inc. | 2.13 Million USD | 10868.553% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -4992.668% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 191.901% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 145308.827% |
| Alimera Sciences, Inc. | -20.13 Million USD | -1039.866% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 576.54% |
| Silver Spike Investment Corp. | 7.34 Million USD | 3226.355% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -3380.775% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 4740.604% |
| Journey Medical Corporation | -3.85 Million USD | -5855.823% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -2711.13% |
| Alpha Teknova, Inc. | -36.78 Million USD | -523.92% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -1182.071% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 2010.246% |
| PainReform Ltd. | -9.34 Million USD | -2355.885% |
| Cosmos Health Inc. | -18.54 Million USD | -1137.568% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | -43.177% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -2132.709% |
| Embecta Corp. | 70.4 Million USD | 425.963% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -5234.416% |
| Talphera, Inc. | -18.39 Million USD | -1147.366% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 646.962% |
| Incannex Healthcare Limited | -18.45 Million USD | -1143.176% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1044.111% |
| Shineco, Inc. | -22.44 Million USD | -922.218% |
| Procaps Group, S.A. | 42.54 Million USD | 639.44% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 1321.992% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -2815.856% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 170.25% |
| Alvotech | -551.73 Million USD | 58.408% |
| Hempacco Co., Inc. | -13.12 Million USD | -1648.259% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 743.841% |
| Bright Green Corporation | -13.12 Million USD | -1648.05% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | -9.668% |
| Kamada Ltd. | 8.28 Million USD | 2870.134% |
| Indivior PLC | 2 Million USD | 11573.893% |
| Evoke Pharma, Inc. | -7.79 Million USD | -2844.933% |
| Flora Growth Corp. | -57.03 Million USD | -302.339% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1044.111% |
| Evolus, Inc. | -61.68 Million USD | -272.016% |
| HUTCHMED (China) Limited | 100.78 Million USD | 327.702% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 266.838% |
| Akanda Corp. | -32.27 Million USD | -611.007% |